The Prognosis of Adult Burkitt's Cell Leukemia in Real-Life Clinical Practice

Creative Commons License

Malkan Ü. Y., GÜNEŞ G., GÖKER H., HAZNEDAROĞLU İ. C., Acar K., ELİAÇIK E., ...Daha Fazla

TURKISH JOURNAL OF HEMATOLOGY, cilt.33, sa.4, ss.281-285, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 33 Sayı: 4
  • Basım Tarihi: 2016
  • Doi Numarası: 10.4274/tjh.2015.0088
  • Dergi Adı: TURKISH JOURNAL OF HEMATOLOGY
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, TR DİZİN (ULAKBİM)
  • Sayfa Sayıları: ss.281-285
  • Anahtar Kelimeler: Burkitt's cell leukemia, Prognosis, COMPETING RISK, LYMPHOMA, RITUXIMAB, SURVIVAL
  • Hacettepe Üniversitesi Adresli: Evet

Özet

Objective: Many studies reported an improved prognosis in patients with Burkitt's lymphoma obviating the need of stem cell transplantation. However, prognosis of the advanced disease [i.e. Burkitt's cell leukemia (BCL)] has not been reported with current treatment modalities except for a few prospective trials. The aim of this study is to compare the prognoses of BCL patients with similarly treated and nontransplanted patients with other types of acute lymphoblastic leukemia (ALL) and with ALL patients that underwent allogeneic stem cell transplantation (ASCT) in their first remissions.